close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by EMulate Therapeutics, Inc.

EMulate Therapeutics Opens Community Investment Round on Wefunder, Offering Public Access to Groundbreaking Digital Therapeutics Platform
From EMulate Therapeutics, Inc.
Via GlobeNewswire
EMulate Therapeutics Inc. Announces Publication of Pre-Clinical Mouse Model Demonstrating Direct Evidence of Immune Checkpoint Receptor Knock-Down in a Mouse Glioblastoma Model
From EMulate Therapeutics, Inc.
Via Business Wire
EMulate Therapeutics Announces the Publication of the Evaluation of Its Ultra-Low Radiofrequency Energy Device in Murine Model of Glioblastoma in BMC Bioelectric Medicine
From EMulate Therapeutics, Inc.
Via Business Wire
EMulate Therapeutics Inc. Announces Publication of Clinical Results at the SNO 2023 Conference: GBM and DIPG
From EMulate Therapeutics, Inc.
Via Business Wire
EMulate Therapeutics Announces the Publication of Its Phase I/II Results in CNS Oncology: “An Expanded Safety/Feasibility Study of the EMulate Therapeutics Voyager™ System in Patients with Recurrent Glioblastoma”
From EMulate Therapeutics, Inc.
Via Business Wire
EMulate Therapeutics Announces Brett Greene, Veteran in the Psychedelic and Cannabinoid Biotechnology Industry, as a Company Advisor
From EMulate Therapeutics, Inc.
Via Business Wire
EMulate Therapeutics Announces the Incorporation of a Third Wholly Owned Subsidiary
From EMulate Therapeutics, Inc.
Via AccessWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today